Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma

Genes Chromosomes and Cancer

Volumn 32, Issue 3, 2001, Pages 250-264

  Baccon, Patricia Le ^a,b   Leroux, Dominique ^a   Dascalescu, Christina ^a   Duley, Samuel ^a   Marais, Danielle ^b   Esmenjaud, Eliane ^b   Sotto, Jean Jacques ^a,b   Callanan, Mary ^a  

^a INSTITUT ALBERT BONNIOT   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CHROMOSOME 1; CHROMOSOME 1Q; CHROMOSOME BREAKAGE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HETEROCHROMATIN; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PATHOGENESIS; PRIORITY JOURNAL; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PROTEINS; CHROMOSOME BANDING; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; HETEROCHROMATIN; HUMANS; KARYOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; SEQUENCE DELETION; TELOMERE; TRANSLOCATION, GENETIC;

EID: 0034797155     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.1189     Document Type: Article

References (63)

1. Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma
2. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies
3. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas
4. Indolent lymphomas. Different entities and diagnostic problems
5. Trisomy 1q generating translocations in Wilms tumor
6. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin
7. Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division
8. Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: Rearrangements of DNA satellite II and new recurrent translocations
9. Implication of cyclin D1 in malignant lymphoma
10. The IgG Fe receptor, FegammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma
11. Frequent translocacion t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
12. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts
13. A YAC contig map of the human genome
14. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding
15. Cloning of human satellite 3 DNA. Different components are on different chromosomes
16. Deletion 7q in B-cell lowgrade lymphoid malignancies: A cytogenetic/fluorescence in situ hybridization and immunopathologic study
17. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features
18. Cytogenetic studies in non-African Burkitt lymphoma
19. MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets
20. Three genes for the human high affinity Fc receptor for IgG (Fe gamma RI) encode four distinct transcription products
21. Locus control region function and heterochromatin-induced position effect variegation
22. Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas
23. A functional enhancer suppresses silencing of a transgene and prevents its localization close to centrometric heterochromatin
24. Physical mapping of the human connexin 40 (GJA5), flavin-containing monooxygenase 5, and natriuretic peptide receptor a genes on 1q21
25. MUC1 dysregulation as the consequence of a t(1;14)(q21;q32) translocation in an extranodal lymphoma
26. JTB: A novel membrane protein gene at 1q21 rearranged in a jumping translocation
27. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy
28. Molecular cloning of a novel human cDNA on chromosome 1q21 and its mouse homolog encoding a nuclear protein with DNA-binding ability
29. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
30. The chromo and SET domains of the Clr4 protein are essential for silencing in fission yeast
31. Cytogenetic evolution patterns in non-Hodgkin's lymphoma
32. Translocations between the long arms of chromosomes 1 and 5 in hematologic malignancies arc strongly associated with neoplasms of the myeloid lineages
33. Mammalian chromodomain proteins: Their role in genome organisation and expression
34. Two-color FISH characterization of i(1q) and der(1;16) in human breast cancer cells
35. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2
36. Molecular determinants for targeting heterochromatin protein 1-mediated gene silencing: Direct chromoshadow domain-KAP-1 corepressor interaction is essential
37. Highresolution YAC fragmentation map of 1q21
38. Switching gene swi6, involved in repression of silent mating-type loci in fission yeast, encodes a homologue of chromatin-associated proteins from Drosophila and mammals
39. Mechanisms of silencing in Saccharomyces cerevisiae
40. Genetic analysis of the epidermal differentiation complex (EDC) on human chromosome 1q21: Chromosomal orientation, new markers, and a 6-Mb YAC contig
41. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)
42. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms
43. A novel cyclin encoded by a bcl1-linked candidate oncogene
44. Der(16)t(1;16) is a secondary chromosome aberration in at least eighteen different types of human cancer
45. Role of histone H3 lysine 9 methylation in epigenetic control of heretochromatin assembly
46. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment
47. Chromosomes and survival in multiple myeloma. A banding study of 25 cases
48. Regulation of chromatin structure by site-specific histone H3 methyltransferases
49. KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: A potential role for Kruppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing
50. The t(1;12)(q21; p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion
51. The human polycomb group complex associates with pericentromeric heterochromatin to form a novel nuclear domain
52. Jumping translocations of chromosome 1q in multiple myeloma: Evidence for a mechanism involving decondensation of pericentromeric heterochromatin
53. Chromosomal analysis in multiple myeloma: Cytogenetic evidence of two different diseases
54. WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma
55. Low level of DNA repair in human chromosome 1 heterochromatin
56. A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells
57. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation
58. Heterochromatin and gene expression in Drosophila
59. Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21
60. Characterization of a candidate bcl-1 gene
61. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene
62. Frequent alterations of evolutionarily conserved regions of chromosome 1 in human malignant melanoma